Synfini

Menlo Park, United States

Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.

$8.9M raised

Jul 2025

Venture - Series Unknown

Top Investors

GaingelsFoothill VenturesMana VenturesTrust VenturesFerocity Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Synfini raised?

Synfini has raised $8.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.

Who are Synfini's investors?

Synfini's investors include Gaingels, Foothill Ventures, Mana Ventures, Trust Ventures, Ferocity Capital.

Where is Synfini headquartered?

Synfini is headquartered in Menlo Park, United States.

What does Synfini do?

Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.

What stage is Synfini at?

Synfini is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 7, 2025.

MLA

"Synfini — Funding & Investors." VCBacked, July 7, 2025, https://www.vcbacked.co/company/synfini. Accessed June 3, 2026.

APA

VCBacked. (2025). Synfini — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/synfini

Wikipedia (cite web)

{{cite web |title=Synfini — Funding & Investors |url=https://www.vcbacked.co/company/synfini |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 7, 2025.